SRDX stock falls more than 26% so far this year. However, this provides a unique opportunity to generate double-digit returns ...

On March 6, 2025, the Federal Trade Commission (FTC) filed a lawsuit in federal court challenging GTCR BC Holdings, LLC's (GTCR) proposed ...

In the FTC’s first merger challenge of the new administration, the FTC voted 4-0 last week to challenge the proposed ...

The Federal Trade Commission has filed a lawsuit to block private equity firm GTCR BC Holdings from acquiring Surmodics, a medical technology company, arguing the deal would reduce competition for ...

Archimed has bought BioVendor, with plans to build and internationalize the Czech diagnostics company. Archimed sees ...

GTCR already owns the second largest medical device coatings manufacturer, Biocoat, and the FTC holds market monopoly ...

Surmodics has a twelve month low of $25.17 and a twelve month high of $42.44. The company has a quick ratio of 4.29, a current ratio of 5.45 and a debt-to-equity ratio of 0.26.

The New Federal Trade Commission (FTC) Chairman Andrew Ferguson has said he will “stop [former FTC Chair] Lina Khan’s war on mergers,” promising to restore a sense of fairness and speed to ...

Surmodics, Inc. SRDX recently provided a statement in response to the U.S. Federal Trade Commission (“FTC”) blocking the proposed acquisition of Surmodics by funds affiliated with GTCR LLC ...

(Tepper, 3/6) Modern Healthcare: FTC Sues To Block GTCR, Surmodics Deal The Federal Trade Commission sued to block private equity firm GTCR BC Holdings' acquisition of medical device coating company ...

Surmodics stock drops 4.76% in premarket trading following news that the FTC will challenge its proposed acquisition by GTCR.

Surmodics, Inc. (NASDAQ:SRDX), a medical technology firm with a market capitalization of $424 million, is set to defend its planned merger with affiliates of GTCR LLC in court, following the U.S.